サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：バクテリオファージの世界市場規模：細菌タイプ別、用途別、投与経路別、地域別の予測（2022年～2028年）
市場調査レポート
商品コード
1073969

バクテリオファージの世界市場規模：細菌タイプ別、用途別、投与経路別、地域別の予測（2022年～2028年）

Global Bacteriophage Market Size study, by Bacteria Type, by Application, by Route of Administration and Regional Forecasts 2022-2028
出版日: | 発行: Bizwit Research & Consulting LLP | ページ情報: 英文 | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.95円
バクテリオファージの世界市場規模：細菌タイプ別、用途別、投与経路別、地域別の予測（2022年～2028年）
出版日: 2022年05月06日
発行: Bizwit Research & Consulting LLP
ページ情報: 英文
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のバクテリオファージの市場規模は、予測期間である2022年～2028年に4.5%以上の健全な成長率で拡大すると予測されています。

作られる抗生物質耐性感染症の増加、入院治療の増加、および薬剤耐性の発生率上昇が、予測期間にわたってバクテリオファージの採用を促進しています。また、治療法開発のための研究活動の進展とEコマース分野における製薬会社のシェア上昇は、同市場の全体的な成長を後押しする可能性が高いです。

しかし、大手製薬会社による投資不足と臨床試験に関連する多額の費用が、2022年～2028年の予測期間中の市場拡大を妨げる可能性があります。

当レポートでは、世界のバクテリオファージ市場を調査し、市場の概要、業界分析、COVID-19によるリスク評価、細菌タイプ別、用途別、投与経路別、地域別の分析、および競合情報などを提供しています。

目次

第1章 エグゼクティブサマリー

第2章 世界のバクテリオファージ市場：定義と範囲

第3章 世界のバクテリオファージ市場：市場力学

  • バクテリオファージ市場：影響分析（2020年～2028年）

第4章 世界のバクテリオファージ市場：業界分析

  • ポーターのファイブフォースモデル
  • PEST分析
  • 投資採用モデル
  • アナリストの推奨事項と結論
  • 主要な投資機会
  • 主要な成功戦略

第5章 リスク評価：COVID-19の影響

    • 用途に対するCOVID-19の全体的な影響の評価
    • COVID-19以前・以後の市場シナリオ

第6章 世界のバクテリオファージ市場：細菌タイプ別

  • 市場スナップショット
  • 実績 - 潜在的な分析
  • 推定と予測（2018年～2028年）
  • サブセグメント分析
    • サルモネラバクテリオファージ
    • 連鎖球菌バクテリオファージ
    • 大腸菌
    • 連鎖球菌・シュードモナス菌バクテリオファージ

第7章 世界のバクテリオファージ市場：用途別

  • 市場スナップショット
  • 実績 - 潜在的な分析
  • 推定と予測（2018年～2028年）
  • サブセグメント分析
    • 診断
    • 食品・飲料
    • 農業
    • 抗菌薬の発見
    • 獣医

第8章 世界のバクテリオファージ市場：投与経路別

  • 市場スナップショット
  • 実績 - 潜在的な分析
  • 推定と予測（2018年～2028年）
  • サブセグメント分析
    • 局所
    • 静脈内
    • 経鼻
    • 経口・経直腸

第9章 世界のバクテリオファージ市場：地域別分析

  • 地域別市場のスナップショット
  • 北米
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • スペイン
    • イタリア
    • その他欧州
  • アジア太平洋地域
    • 中国
    • インド
    • 日本
    • オーストラリア
    • 韓国
    • その他アジア太平洋地域
  • ラテンアメリカ
    • ブラジル
    • メキシコ
  • 世界のその他の地域

第10章 競合情報

  • 主要市場戦略
  • 企業プロファイル
  • Arthur Andrew Medical
  • Deerland Probiotics & Enzymes
  • Biochimpharm
  • Micreos Human Health B.V.
  • Armata Pharmaceuticals
  • Pherecydes Pharmaceuticals
  • Adaptive Phage Therapeutics
  • PhagoMed Biopharma GmbH
  • Phagelux, Inc.
  • Intralytix,Inc.

第11章 調査プロセス

図表

LIST OF TABLES

  • TABLE 1. Global Bacteriophage market, report scope
  • TABLE 2. Global Bacteriophage market estimates & forecasts by Region 2018-2028 (USD Billion)
  • TABLE 3. Global Bacteriophage market estimates & forecasts by Test Type 2018-2028 (USD Billion)
  • TABLE 4. Global Bacteriophage market estimates & forecasts by Application 2018-2028 (USD Billion)
  • TABLE 5. Global Bacteriophage market estimates & forecasts by Route of Administration 2018-2028 (USD Billion)
  • TABLE 6. Global Bacteriophage market by segment, estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 7. Global Bacteriophage market by region, estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 8. Global Bacteriophage market by segment, estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 9. Global Bacteriophage market by region, estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 10. Global Bacteriophage market by segment, estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 11. Global Bacteriophage market by region, estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 12. Global Bacteriophage market by segment, estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 13. Global Bacteriophage market by region, estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 14. Global Bacteriophage market by segment, estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 15. Global Bacteriophage market by region, estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 16. U.S. Bacteriophage market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 17. U.S. Bacteriophage market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 18. U.S. Bacteriophage market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 19. Canada Bacteriophage market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 20. Canada Bacteriophage market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 21. Canada Bacteriophage market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 22. UK Bacteriophage market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 23. UK Bacteriophage market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 24. UK Bacteriophage market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 25. Germany Bacteriophage market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 26. Germany Bacteriophage market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 27. Germany Bacteriophage market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 28. RoE Bacteriophage market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 29. RoE Bacteriophage market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 30. RoE Bacteriophage market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 31. China Bacteriophage market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 32. China Bacteriophage market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 33. China Bacteriophage market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 34. India Bacteriophage market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 35. India Bacteriophage market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 36. India Bacteriophage market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 37. Japan Bacteriophage market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 38. Japan Bacteriophage market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 39. Japan Bacteriophage market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 40. RoAPAC Bacteriophage market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 41. RoAPAC Bacteriophage market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 42. RoAPAC Bacteriophage market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 43. Brazil Bacteriophage market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 44. Brazil Bacteriophage market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 45. Brazil Bacteriophage market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 46. Mexico Bacteriophage market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 47. Mexico Bacteriophage market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 48. Mexico Bacteriophage market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 49. RoLA Bacteriophage market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 50. RoLA Bacteriophage market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 51. RoLA Bacteriophage market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 52. Row Bacteriophage market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 53. Row Bacteriophage market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 54. Row Bacteriophage market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 55. List of secondary Detection Bacteria Types, used in the study of global Bacteriophage market
  • TABLE 56. List of primary Detection Bacteria Types, used in the study of global Bacteriophage market
  • TABLE 57. Years considered for the study
  • TABLE 58. Exchange rates considered

LIST OF FIGURES

List of figures

  • FIG 1. Global Bacteriophage market, research methodology
  • FIG 2. Global Bacteriophage market, market estimation techniques
  • FIG 3. Global market size estimates & forecast methods
  • FIG 4. Global Bacteriophage market, key trends 2021
  • FIG 5. Global Bacteriophage market, growth prospects 2022-2028
  • FIG 6. Global Bacteriophage market, porters 5 force model
  • FIG 7. Global Bacteriophage market, pest analysis
  • FIG 8. Global Bacteriophage market, value chain analysis
  • FIG 9. Global Bacteriophage market by segment, 2018 & 2028 (USD Billion)
  • FIG 10. Global Bacteriophage market by segment, 2018 & 2028 (USD Billion)
  • FIG 11. Global Bacteriophage market by segment, 2018 & 2028 (USD Billion)
  • FIG 12. Global Bacteriophage market by segment, 2018 & 2028 (USD Billion)
  • FIG 13. Global Bacteriophage market by segment, 2018 & 2028 (USD Billion)
  • FIG 14. Global Bacteriophage market, regional snapshot 2018 & 2028
  • FIG 15. North America Bacteriophage market 2018 & 2028 (USD Billion)
  • FIG 16. Europe Bacteriophage market 2018 & 2028 (USD Billion)
  • FIG 17. Asia Pacific Bacteriophage market 2018 & 2028 (USD Billion)
  • FIG 18. Latin America Bacteriophage market 2018 & 2028 (USD Billion)
  • FIG 19. Global Bacteriophage market, company market share analysis (2021)
目次

Global Bacteriophage Market is valued at approximately USD xyz billion in 2021 and is anticipated to grow with a healthy growth rate of more than 4.5 % over the forecast period 2022-2028. A bacteriophage is a virus that causes bacteria to become infected. Because bacteriophages destroy their host cells, the word "bacteriophage" clearly translates as "bacteria eater." Bacteriophages are all made up of a nucleic acid molecule encased in a protein framework. A bacteriophage infects the host cell by attaching itself to susceptible bacteria. Rising manufacturing of antibiotic resistant infections, rising inpatient care, and rising incidence of antimicrobial resistance have driven the adoption of Bacteriophage across the projected period. For Instance: As per the reports of the Centers for Disease Control and Prevention (CDC). Antibiotic-resistant infections kill at least 23,000 people in the United States and around 33,000 people in Europe. Also, rising research activities for the development of Therapies and rising share of pharmaceutical companies in e-commerce sector are most likely to boost the overall growth of the Bacteriophage market. However, lack of investment by large pharmaceutical companies and large cost associated with clinical trials can obstruct the market's expansion over the projection period of 2022-2028.

The key regions considered for the global Bacteriophage market study include Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading region across the world. Rising failure of antibiotic treatments and need for alternative therapies are driving the market growth in North America. Whereas, Asia Pacific is also anticipated to exhibit the highest growth rate over the forecast period 2022-2028. The market is expected to grow during the projected period, due to rapidly evolving biotechnology infrastructure.

Major market players included in this report are:

Arthur Andrew Medical

Deerland Probiotics & Enzymes

Biochimpharm

Micreos Human Health B.V.

Armata Pharmaceuticals

Pherecydes Pharmaceuticals

Adaptive Phage Therapeutics

PhagoMed Biopharma GmbH

Phagelux, Inc.

Intralytix,Inc.

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Bacteria Type:

Salmonella Bacteriophage

Streptococcus Bacteriophage

Escherichia Coli

Streptococcus and Psuedomonas Bacteriophage

By Application:

Diagnostic

Food & Beverages

Agriculture

Antimicrobial Drug Discovery

Veterinary

By Route of Administration:

Topical

Intravenous

Trans nasal

Oral & trans rectal

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year - 2018, 2019, 2020

Base year - 2021

Forecast period - 2022 to 2028

Target Audience of the Global Bacteriophage Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Billion)
    • 1.2.1. Bacteriophage Market, by Region, 2020-2028 (USD Billion)
    • 1.2.2. Bacteriophage Market, by Bacteria Type, 2020-2028 (USD Billion)
    • 1.2.3. Bacteriophage Market, by Application, 2020-2028 (USD Billion)
    • 1.2.4. Bacteriophage Market, by Route of Administration, 2020-2028 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Bacteriophage Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Bacteriophage Market Dynamics

  • 3.1. Bacteriophage Market Impact Analysis (2020-2028)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Rising manufacturing of Antibiotic Resistant Infection
      • 3.1.1.2. Rising inpatient care
      • 3.1.1.3. Rising incidence of Antimicrobial Resistance
    • 3.1.2. Market Challenges
      • 3.1.2.1. Lack of Investment by Large Pharmaceutical Companies
      • 3.1.2.2. Large Cost associated with Clinical Trials
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Rising research activities for the development of Therapies
      • 3.1.3.2. Rising share of Pharmaceutical Companies in e-commerce Sector

Chapter 4. Global Bacteriophage Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
    • 4.1.6. Futuristic Approach to Porter's 5 Force Model (2018-2028)
  • 4.2. PEST Analysis
    • 4.2.1. Political
    • 4.2.2. Economical
    • 4.2.3. Social
    • 4.2.4. Technological
  • 4.3. Investment Adoption Model
  • 4.4. Analyst Recommendation & Conclusion
  • 4.5. Top investment opportunity
  • 4.6. Top winning strategies

Chapter 5. Risk Assessment: COVID-19 Impact

    • 5.1.1. Assessment of the overall impact of COVID-19 on the Application
    • 5.1.2. Pre COVID-19 and post COVID-19 market scenario

Chapter 6. Global Bacteriophage Market, by Bacteria Type

  • 6.1. Market Snapshot
  • 6.2. Global Bacteriophage Market by Bacteria Type, Performance - Potential Analysis
  • 6.3. Global Bacteriophage Market Estimates & Forecasts by Bacteria Type, 2018-2028 (USD Billion)
  • 6.4. Bacteriophage Market, Sub Segment Analysis
  • 6.4.1 Salmonella Bacteriophage
  • 6.4.2 Streptococcus Bacteriophage
  • 6.4.3 Escherichia Coli
  • 6.4.4 Streptococcus and Pseudomonas Bacteriophage

Chapter 7. Global Bacteriophage Market, by Application

  • 7.1. Market Snapshot
  • 7.2. Global Bacteriophage Market by Application, Performance - Potential Analysis
  • 7.3. Global Bacteriophage Market Estimates & Forecasts by Application, 2018-2028 (USD Billion)
  • 7.4. Bacteriophage Market, Sub Segment Analysis
  • 7.4.1 Diagnostic
  • 7.4.2 Food & Beverages
  • 7.4.3 Agriculture
  • 7.4.4 Antimicrobial Drug Discovery
  • 7.4.5 Veterinary

Chapter 8. Global Bacteriophage Market, by Route of Administration

  • 8.1. Market Snapshot
  • 8.2. Global Bacteriophage Market by Route of Administration, Performance - Potential Analysis
  • 8.3. Global Bacteriophage Market Estimates & Forecasts by Route of Administration, 2018-2028 (USD Billion)
  • 8.4. Bacteriophage Market, Sub Segment Analysis
  • 8.4.1 Topical
  • 8.4.2 Intravenous
  • 8.4.3 Trans nasal
  • 8.4.4 Oral & trans rectal

Chapter 9. Global Bacteriophage Market, Regional Analysis

  • 9.1. Bacteriophage Market, Regional Market Snapshot
  • 9.2. North America Bacteriophage Market
    • 9.2.1. U.S. Bacteriophage Market
      • 9.2.1.1. Bacteria Type breakdown estimates & forecasts, 2018-2028
      • 9.2.1.2. Application breakdown estimates & forecasts, 2018-2028
      • 9.2.1.3. Enterprises Size breakdown estimates & forecasts, 2018-2028
    • 9.2.2. Canada Bacteriophage Market
  • 9.3. Europe Bacteriophage Market Snapshot
    • 9.3.1. U.K. Bacteriophage Market
    • 9.3.2. Germany Bacteriophage Market
    • 9.3.3. France Bacteriophage Market
    • 9.3.4. Spain Bacteriophage Market
    • 9.3.5. Italy Bacteriophage Market
    • 9.3.6. Rest of Europe Bacteriophage Market
  • 9.4. Asia-Pacific Bacteriophage Market Snapshot
    • 9.4.1. China Bacteriophage Market
    • 9.4.2. India Bacteriophage Market
    • 9.4.3. Japan Bacteriophage Market
    • 9.4.4. Australia Bacteriophage Market
    • 9.4.5. South Korea Bacteriophage Market
    • 9.4.6. Rest of Asia Pacific Bacteriophage Market
  • 9.5. Latin America Bacteriophage Market Snapshot
    • 9.5.1. Brazil Bacteriophage Market
    • 9.5.2. Mexico Bacteriophage Market
  • 9.6. Rest of The World Bacteriophage Market

Chapter 10. Competitive Intelligence

  • 10.1. Top Market Strategies
  • 10.2. Company Profiles
  • 10.2.1 Arthur Andrew Medical
    • 10.2.1.1 Key Information
    • 10.2.1.2 Overview
    • 10.2.1.3 Financial (Subject to Data Availability)
    • 10.2.1.4 Product Summary
    • 10.2.1.5 Recent Developments
  • 10.2.2 Deerland Probiotics & Enzymes
  • 10.2.3 Biochimpharm
  • 10.2.4 Micreos Human Health B.V.
  • 10.2.5 Armata Pharmaceuticals
  • 10.2.6 Pherecydes Pharmaceuticals
  • 10.2.7 Adaptive Phage Therapeutics
  • 10.2.8 PhagoMed Biopharma GmbH
  • 10.2.9 Phagelux, Inc.
  • 10.2.10 Intralytix,Inc.

Chapter 11. Research Process

11.1 Research Process

  • 11.1.1 Data Mining
  • 11.1.2 Analysis
  • 11.1.3 Market Estimation
  • 11.1.4 Validation
  • 11.1.5 Publishing

11.2 Research Attributes

11.3 Research Assumption